Conclusion Semaglutide treatment offers a promising option for individuals struggling with type 2 diabetes, obesity, and related cardiovascular risks
Artificial intelligence in anti-obesity drug discovery: unlocking next-generation therapeutics
The key finding was selectivity: chemogenetic activation of NTS GLP-1 neurons reduced cocaine seeking in drug exposed animals without altering food intake
Managing diabetes while using GLP-1 medications creates a specific nutritional challenge: youre eating significantly less, which makes consistent nutrition harder and for people with diabetes, inconsistent nutrition means additional complexity around blood sugar management
Depression affects an There are several modifiable lifestyle factors including Over the past few months alone, researchers have highlighted how dietary choices, exercise, and medication treating other chronic conditions might impact a persons risk of developing depression
Switching scenarios and practical examples Consider a person on dulaglutide who experiences plateaued A1C and persistent appetite
